Hans Hoogduin

Associate Professor

Strategic program(s):

Research groups

Precision imaging

Research aim

Our research lines incorporate inventions of MR technology to be able to see the unseen for advancing medicine. Our clinical research focus areas are cancer, dementia, cardiovascular, stroke and MSK.

Go to group

Recent publications

Amide proton transfer weighted imaging in pediatric neuro-oncology Iris V. Obdeijn, Evita C. Wiegers, Lejla Alic, Sabine L.A. Plasschaert, Mariëtte E.G. Kranendonk, Hans M. Hoogduin, Dennis W.J. Klomp, Jannie P. Wijnen, Maarten H. Lequin
NMR in Biomedicine, 2024, vol. 37
Introduction of ultra-high-field MR brain imaging in infants I. M. van Ooijen, K. V. Annink, M. J.N.L. Benders, J. Dudink, T. Alderliesten, F. Groenendaal, M. L. Tataranno, M. H. Lequin, J. M. Hoogduin, F. Visser, A. J.E. Raaijmakers, D. W.J. Klomp, E. C. Wiegers, J. P. Wijnen, N. E. van der Aa
Neuroimage: Reports, 2023, vol. 3
Ultra-high Field MRI of the Kidney Anneloes de Boer, J. M. Hoogduin, G. J. Metzger
2023, p.437-452
The use of variable delay multipulse chemical exchange saturation transfer for separately assessing different CEST pools in the human brain at 7T Bárbara Schmitz-Abecassis, Elena Vinogradov, Jannie P Wijnen, Thijs van Harten, Evita C Wiegers, Hans Hoogduin, Matthias J P van Osch, Ece Ercan
Magnetic Resonance in Medicine, 2021, vol. 87, p.872-883
Feasibility of the APRICOT-trial: identifying MRI biomarkers for radiation-induced cognitive changes E. van Grinsven, A. Bhogal, J. Guichelaar, J. Siero, H. Hoogduin, M. van Zandvoort, J. Verhoeff, M. Philippens
Radiotherapy and Oncology, 2021, vol. 161, p.S893-S894
No need to detune transmitters in 32-channel receiver arrays at 7 T Mark Gosselink, Hans Hoogduin, Martijn Froeling, Dennis W J Klomp
NMR in Biomedicine, 2021, vol. 34